维生素D与妊娠期高血压疾病的相关性研究进展

张静, 韩雪, 孙敬霞

中国生育健康杂志 ›› 2020, Vol. 31 ›› Issue (1) : 84-86.

PDF(365 KB)
欢迎访问《中国生育健康杂志》官方网站!今天是 2025年4月5日 星期六
PDF(365 KB)
中国生育健康杂志 ›› 2020, Vol. 31 ›› Issue (1) : 84-86.
综述

维生素D与妊娠期高血压疾病的相关性研究进展

  • 张静, 韩雪, 孙敬霞
作者信息 +
文章历史 +

摘要

妊娠期高血压疾病(hypertensive disorder complicating pregnancy,HDP)是孕妇在妊娠期所患的一种特有疾病,严重危害母婴的健康,同时也是导致我国孕产妇和围生儿死亡的最重要原因之一。维生素D、维生素D受体和HDP关系密切。流行病学资料表明,妊娠期高血压、子痫前期患者妊娠晚期血清1,25(OH)2D3水平下降,胎盘维生素D受体低表达、与维生素D抵抗有关。本文总结了维生素D、维生素D受体、维生素D抵抗及其与HDP相关性的研究进展。

关键词

妊娠期高血压疾病 / 维生素D / 维生素D受体 / 维生素D抵抗

引用本文

导出引用
张静, 韩雪, 孙敬霞. 维生素D与妊娠期高血压疾病的相关性研究进展[J]. 中国生育健康杂志, 2020, 31(1): 84-86

参考文献

1 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2015).中华妇产科杂志,2015,50:721-728.
2 Lechtermann C,Hauffa BP,Herrmann R,et al.Maternal vitamin D status in preeclampsia:seasonal changes are not influenced by placental gene expression of vitamin D metabolizing enzymes.PLoS One 2014;9:e105558.
3 金萌萌,巴建明.维生素D抵抗与骨代谢.药品评价,2014,11:22-24,44.
4 Holick MF.Vitamin D:A millenium perspective.J Cell Biochem 2003;88:296-307.
5 蒲元芳,谢艳,战玉峰,等.孕妇血清25羟基维生素D水平与妊娠合并症的关系.生殖医学杂志,2015,24:79-83.
6 Olmos-Ortiz A,Avila E,Durand-Carbajal M,et al.Regulation of calcitriol biosynthesis and activity:focus on gestational vitamin D deficiency and adverse pregnancy outcomes.Nutrients 2015;7:443-480.
7 Omdahl JL,Morris H A,May B K.Hydroxylase enzymes of the vitamin D pathway:expression,function,and regulation.Annu Rev Nutr 2002;22:139-166.
8 Avila E,Díaz L,Barrera D,et al.Regulation of Vitamin D hydroxylases gene expression by 1,25-dihydroxyvitamin D3 and cyclic AMP in cultured human syncytiotrophoblasts.J Steroid Biochem Mol Biol 2007;103:90-96.
9 Mizwicki MT,Norman AW.The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling.Sci Signal 2009;2:re4.
10 Luk J,Torrealday S,Neal PG,et al.Relevance of vitamin D in reproduction.Hum Reprod 2012;27:3015-3027.
11 Deeb KK,Trump DL,Johnson CS.Vitamin D signalling pathways in cancer:potential for anticancer therapeutics.Nat Rev Cancer 2007;7:684-700.
12 Bikle D.Nonclassic actions of vitamin D.J Clin Endocrinol Metab 2009;94:26-34.
13 Chen H,Hewison M,Hu B,et al.Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements:a cause of vitamin D resistance.Proc Natl Acad Sci U S A,2003,100:6109-6114.
14 Carpenter B,Mackay C,Alnabulsi A,et al.The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression.Biochim Biophys Acta,2006,1765:85-100.
15 Chen H,Hewison M,Adams JS.Functional characterization of heterogeneous nuclear ribonuclear protein C1/C2 in vitamin D resistance:a novel response element-binding protein.J Biol Chem,2006,281:39114-39120.
16 Chan SY,Susarla R,Canovas D,et al.Vitamin D promotes human extravillous trophoblast invasion invitro.Placenta,2015,36:403-409.
17 Rong M,Yang G,Shuang Z,et al.Expressions of vitamin D metabolic components VDBP,CYP2R1,CYP27B1,CYP24A1,and VDR in placentas from normal and preeclamptic pregnancies.Am J Physiol Endocrinol Metab.2012,303:E928-935.
18 Kienreich K,Grübler M,Tomaschitz A,et al.Vitamin D,arterial hypertension & cerebrovascular disease.Indian J Med Res,2013,137:669-679.
19 Pospechova K,Rozehnal V,Stejskalova L,et al.Expression and activity of vitamin D receptor in the human placenta and in choriocarcinoma BeWo and JEG-3 cell lines.Mol Cell Endocrinol,2009,299:178-187.
20 Moller UK,Streym S,Mosekilde L,et al.Changes in calcitropic hormones,bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum:a controlled cohort study.Osteoporos Int,2013,24(4):1307-1320.
21 Bodnar LM,Catov J M,Simhan HN,et al.Maternal vitamin D deficiency increases the risk of preeclampsia.J Clin Endocrinol Metab,2007,92:3517-3522.
22 Barrera D,Díaz L,Noyola-Martínez N,et al.Vitamin D and inflammatory cytokines in healthy and preeclamptic pregnancies.Nutrients,2015,7:6465-6490.
23 Shin JS,Choi MY,Longtine MS,et al.Vitamin D effects on pregnancy and the placenta.Placenta,2010,31:1027-1034.
24 Nguyen TP,Yong HE,Chollangi T,et al.Placental vitamin D receptor expression is decreased in human idiopathic fetal growth restriction.J Mol Med (Berl),2015,93:795-805.
25 Murthi P,Yong HEJ,Ngyuen TPH,et al.Role of the Placental Vitamin D receptor in modulating feto-placental growth in fetal growth restriction and preeclampsia-affected pregnancies.Front Physiol,2016,7:43.

PDF(365 KB)

298

Accesses

0

Citation

Detail

段落导航
相关文章

/